Zeo Scientifix, INC. (ZEOX) — 10-Q Filings

10-Q Filings (6)

• Zeo ScientifiX Losses Double Amid Soaring Expenses, Despite Revenue Growth — Sep 15, 2025 Risk: high
  Zeo ScientifiX, Inc. (ZEOX) reported a significant increase in net loss for the three months ended July 31, 2025, reaching $2,072,000, up from $1,012,000 in the
• Zeo ScientifiX Revenue Up, But Losses Widen to $2M — Jun 16, 2025 Risk: high
  Zeo ScientifiX, Inc. reported a net loss of $1,059,600 for the three months ended April 30, 2025, a significant increase from the net loss of $673,700 for the s
• Zeo ScientifiX Files Q1 2025 10-Q — Mar 17, 2025 Risk: medium
  Zeo ScientifiX, Inc. filed its 10-Q for the period ending January 31, 2025. The company, formerly known as Organicell Regenerative Medicine, Inc., is in the bio
• Zeo ScientifiX Files 10-Q for July 2024 Period — Sep 16, 2024 Risk: medium
  Zeo ScientifiX, Inc. filed its 10-Q for the period ending July 31, 2024. The company, formerly known as Organicell Regenerative Medicine, Inc., is in the biolog
• Zeo ScientifiX Files Q2 10-Q — Jun 14, 2024 Risk: medium
  Zeo ScientifiX, Inc. filed its 10-Q for the period ending April 30, 2024. The company, formerly known as Organicell Regenerative Medicine, Inc., is in the biolo
• Zeo ScientifiX, Inc. Files 10-Q for Period Ending January 31, 2024 — Mar 18, 2024 Risk: medium
  Zeo ScientifiX, Inc. (ZEOX) filed a Quarterly Report (10-Q) with the SEC on March 18, 2024. Zeo ScientifiX, Inc. filed a 10-Q for the period ending January 31,

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX